Literature DB >> 10888318

A rapid spectrofluorimetric technique for determining drug-serum protein binding suitable for high-throughput screening.

H H Parikh1, K McElwain, V Balasubramanian, W Leung, D Wong, M E Morris, M Ramanathan.   

Abstract

PURPOSE: To develop and validate a rapid method for determining the dissociation constants with which pharmaceutical candidates and drugs bind to serum albumin and to alpha1-acid glycoprotein with the goal of deducing the extent of binding.
METHODS: The quenching of the intrinsic tryptophan fluorescence of serum albumin and alpha1-acid glycoprotein was monitored by spectrofluorimetry and the data were used to calculate the apparent dissociation constant. Sodium warfarin was used to probe the warfarin-binding site of serum albumin and diazepam was used to probe the benzodiazepine binding site. Additionally, the binding of sodium salicylate, phenylbutazone, sulfinpyrazone, iophenoxic acid, theophylline, chloramphenicol, acetaminophen, lithium chloride and ampicillin were also investigated. Chlorpromazine hydrochloride and imipramine hydrochloride were used as probes for alpha1-acid glycoprotein. The assays were also extended to the multiwell format. The quenching curves were fitted to the quadratic binding equation to determine the dissociation constants.
RESULTS: Intrinsic fluorescence measurements are an excellent predictor of the drug binding to human serum albumin and to alpha1-acid glycoprotein. These measurements detect binding to the warfarin and benzodiazepine binding sites of human serum albumin. The dissociation constants estimated using the method compare favorably to the dissociation constants previously reported by Epps et al. using extrinsic fluorescence methodology, and the results correlate well with equilibrium dialysis using drug displacement endpoints.
CONCLUSIONS: These measurements can be carried out with small samples and do not require separation of the bound and unbound species. Additionally, the proposed methods eliminate membrane separations, are not compound specific and do not require analytical chromatography or mass spectrometry for quantitation. Spectrofluorimetry may prove to be a useful method for rapidly determining the protein binding of combinatorial libraries.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888318     DOI: 10.1023/a:1007537520620

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  The characterization of two specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

2.  Further characterization of specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

3.  Thyroid function in nephrosis.

Authors:  L RECANT; D S RIGGS
Journal:  J Clin Invest       Date:  1952-08       Impact factor: 14.808

4.  Perfusion-limited of plasma drug binding on hepatic drug extraction.

Authors:  D G Shand; R H Cotham; G R Wilkinson
Journal:  Life Sci       Date:  1976-07-01       Impact factor: 5.037

5.  Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis.

Authors:  J D Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

6.  Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.

Authors:  J A Jansen
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

7.  Effect of altered disopyramide binding on its pharmacologic response in rabbits.

Authors:  J D Huang; S Oie
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

8.  Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein.

Authors:  D E Epps; T J Raub; V Caiolfa; A Chiari; M Zamai
Journal:  J Pharm Pharmacol       Date:  1999-01       Impact factor: 3.765

9.  Spectroscopic techniques in the study of protein binding: the use of 1-anilino-8-naphthalenesulphonate as a fluorescent probe for the study of the binding of iophenoxic and iopanoic acids to human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1973-09       Impact factor: 4.436

10.  Stereospecific and competitive binding of drugs to human serum albumin: a difference circular dichroism approach.

Authors:  G Ascoli; C Bertucci; P Salvadori
Journal:  J Pharm Sci       Date:  1995-06       Impact factor: 3.534

View more
  6 in total

1.  Determination of drug binding to plasma proteins using competitive equilibrium binding to dextran-coated charcoal.

Authors:  Leonid M Berezhkovskiy
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-07-14       Impact factor: 2.745

2.  Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.

Authors:  Michel Tod; Olivier Mir; Natacha Bancelin; Romain Coriat; Audrey Thomas-Schoemann; Fabrice Taieb; Pascaline Boudou-Rouquette; Stanislas Ropert; Judith Michels; Halim Abbas; Jean Philippe Durand; Alain Dauphin; Michel Vidal; Francois Goldwasser; Benoit Blanchet
Journal:  Pharm Res       Date:  2011-06-21       Impact factor: 4.200

3.  An evaluation of a fluorometric method for determining binding parameters of drug-carrier complexes using mathematical models based on total drug concentration.

Authors:  Boontarika Chanvorachote; Ubonthip Nimmannit; Walaisiri Muangsiri; Lee Kirsch
Journal:  J Fluoresc       Date:  2009-04-08       Impact factor: 2.217

4.  Physicochemical properties of epidermal growth factor receptor inhibitors and development of a nanoliposomal formulation of gefitinib.

Authors:  Brian J Trummer; Vandana Iyer; Sathy V Balu-Iyer; Robert O'Connor; Robert M Straubinger
Journal:  J Pharm Sci       Date:  2012-05-11       Impact factor: 3.534

5.  Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.

Authors:  Cristina Tintori; Giulia Iovenitti; Elisa Rita Ceresola; Roberto Ferrarese; Claudio Zamperini; Annalaura Brai; Giulio Poli; Elena Dreassi; Valeria Cagno; David Lembo; Filippo Canducci; Maurizio Botta
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

6.  Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin.

Authors:  Carla Fernandes; Andreia Palmeira; Inês I Ramos; Carlos Carneiro; Carlos Afonso; Maria Elizabeth Tiritan; Honorina Cidade; Paula C A G Pinto; M Lúcia M F S Saraiva; Salette Reis; Madalena M M Pinto
Journal:  Pharmaceuticals (Basel)       Date:  2017-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.